Orcrist Bio Inc. Files With European Competent Authority for a Phase I, Open-Label, Single-Ascending-Dose, Safety Study of HYC750
CALGARY, Canada, February 9 /PRNewswire/ -- Orcrist Bio Inc. (ORC) a biotech company developing stem cell-mobilizing pharmaceuticals, announced today that it has filed with the European Competent…